@article{JTD12596,
author = {Sebastian Nuding and Karl Werdan},
title = {IABP plus ECMO—Is one and one more than two?},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {4},
year = {2017},
keywords = {},
abstract = {Prognosis of patients with cardiogenic shock or after cardiac arrest is poor, with no drugs at hand to substantially lower high mortality. Therefore, all hope is pinned on percutaneous life-supporting devices like intra-aortic balloon pump (IABP), venoarterial extracorporeal membrane oxygenation (VA-ECMO) and others (1-4). The Extracorporeal Life Support (ECLS) Organization Registry International Report 2016 (5) contains information on 78,397 ECLS patients. In Germany, about 5,000 IABPs and 3,000 VA-ECMO systems have been implemented in 2014 (6).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/12596}
}